(Q46030429)

18 December 2017

title

Novel action of 7-O-galloyl-D-sedoheptulose isolated from Corni Fructus as a hypertriglyceridaemic agent. (English)

1 reference

18 December 2017

author

Takashi Tanaka

4

1 reference

18 December 2017

author name string

Takako Yokozawa

1

1 reference

18 December 2017

Chan Hum Park

2

1 reference

18 December 2017

Jeong Sook Noh

3

1 reference

18 December 2017

Eun Ju Cho

5

1 reference

18 December 2017

publication date

1 May 2009

1 reference

18 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

18 December 2017

volume

61

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

653-661

1 reference

18 December 2017

Triglyceride as a risk factor for coronary artery disease.

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Corni fructus as the major herb of Die-Huang-Wan for lowering plasma glucose in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Inhibition of herpes simplex virus infection by tannins and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Fructose, insulin resistance, and metabolic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Integration of metabolism and inflammation by lipid-activated nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Studies on the risk factors for fenofibrate-induced elevation of liver function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Fenofibrate-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Effects of Japanese and Chinese traditional medicine "hachimi-gan" ("ba-wei-wan") on lipid metabolism in rats fed high sugar diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Ellagitannins as active constituents of medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0015

21 January 2018

Identifiers

DOI

10.1211/JPP.61.05.0015

1 reference

18 December 2017

1 reference

18 December 2017